EGFR and neoplasm: In this regard, markers of primordial cancer stem-cells, such as Oct4 and CD133, have been detected in NSCLC cell lines and in tumor specimens of EGFRM+ NSCLC patients with acquired resistance to EGFR-TKIs, suggesting that they play a role in the resistance process [283].